Checkpoint Capital L.P.
SAN FRANCISCO, CA · CIK 1977548 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2025 · limited partnership
- Assets managed$333.8m
- Staff2 · 2 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $333.8m gross assets
- Websitecheckpointlp.com
- Form ADV · 2026-03-27SEC adviser record
- Legal entityCheckpoint Capital L.P. (US)
- Kindhedge funds, futures
- Others nearbySan Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 1
$389.8m
reported value
+39.9% vs Q1 2026
6positions
100.0%in top 10
0 new
3 added
3 reduced
2 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| RHYTHM PHARMACEUTICALS INC RYTM | $131.7m33.79% | Reduced -41.2k |
| ARGENX SE ARGX | $121.8m31.25% | Reduced -21.7k |
| REVOLUTION MEDICINES INC RVMD | $76.9m19.72% | Added +147.8k |
| CYTOKINETICS INC CYTK | $40.5m10.38% | Added +295.0k |
| DISC MEDICINE INC IRON | $17.6m4.51% | Reduced -46.5k |
| TREVI THERAPEUTICS INC TRVI | $1.4m0.36% | Added +25.0k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| SEPTERNA INC SEPN | $2.4m100.3k shares |
| CRINETICS PHARMACEUTICALS IN CRNX | $1.5m40.2k shares |